Canada Life’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,372
Closed -$131K 2316
2023
Q1
$131K Buy
5,372
+593
+12% +$13K ﹤0.01% 1938
2022
Q4
$103K Hold
4,779
﹤0.01% 1981
2022
Q3
$85K Buy
4,779
+1,547
+48% +$20.3K ﹤0.01% 2017
2022
Q2
$31K Hold
3,232
﹤0.01% 2174
2022
Q1
$58K Buy
3,232
+291
+10% +$4.3K ﹤0.01% 2121
2021
Q4
$49K Hold
2,941
﹤0.01% 2179
2021
Q3
$48K Sell
2,941
-2,047
-41% -$22.3K ﹤0.01% 2250
2021
Q2
$31K Hold
4,988
﹤0.01% 2403
2021
Q1
$31K Hold
4,988
﹤0.01% 2438
2020
Q4
$34K Buy
+4,988
New +$31.9K ﹤0.01% 2413
2017
Q2
Sell
-3,651
Closed -$13K 2551
2017
Q1
$13K Hold
3,651
﹤0.01% 2487
2016
Q4
$18K Hold
3,651
﹤0.01% 2503
2016
Q3
$168K Buy
3,651
+1,451
+66% +$81.8K ﹤0.01% 1952
2016
Q2
$112K Hold
2,200
﹤0.01% 2062
2016
Q1
$93K Hold
2,200
﹤0.01% 1842
2015
Q4
$173K Hold
2,200
﹤0.01% 1365
2015
Q3
$89K Sell
2,200
-6,800
-76% -$360K ﹤0.01% 1785
2015
Q2
$467K Buy
9,000
+6,800
+309% +$338K ﹤0.01% 1023
2015
Q1
$102K Hold
2,200
﹤0.01% 1779
2014
Q4
$98K Hold
2,200
﹤0.01% 1769
2014
Q3
$86K Hold
2,200
﹤0.01% 1800
2014
Q2
$93K Buy
+2,200
New +$80.7K ﹤0.01% 1644

Other funds holding ISEE

Canada Life's ISEE Position: Q2 2023 in Review

Canada Life sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 5,372 shares — an estimated $131K sold.

Canada Life first reported a position in ISEE in Q2 2014 and held it in 22 quarters. The position peaked at $467K in Q2 2015. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Canada Life reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Canada Life sold 5,372 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $131K.
  • Canada Life first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 22 quarters.
  • Canada Life's IVERIC bio, Inc. Common Stock position peaked at $467K in Q2 2015.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.